Background: Telehealth can improve access to care for people living with multiple sclerosis (pwMS), but information on its acceptance is limited in Switzerland. Objective: This study aimed to determine the proportion of pwMS willing…
Continue Reading
What You Should Know:
– Philips and Cortechs.ai are strengthening their collaboration to integrate AI-enabled quantitative neuroimaging analytics directly into Philips’ MR systems.
The integration provides clinicians with faster, more objective, and reproducible insights into brain…
Continue Reading
This study aimed to identify and appraise published cost-effectiveness analyses of mobile device-based active remote monitoring technologies for long-term conditions. A systematic literature review (PROSPERO: CRD42023406364) identified studies from Medline and Embase (2008 until…
Continue Reading
This systematic review explores the relationship between digital biomarkers, measured using wearable devices, and fatigue in patients with chronic diseases. Studies included in this review focused on individuals with diseases or conditions in 13…
Continue Reading
Background: Assessing fall risk, especially in individuals with neurological disorders, is essential to prevent hospitalization, hypomobility, and reduced functional independence. Wearable sensors are increasingly used in neurorehabilitation, as they enable unsupervised fall risk assessment…
Continue Reading
Early prediction of disability progression in multiple sclerosis (MS) remains challenging despite its critical importance for therapeutic decision-making. We present the first systematic evaluation of personalized federated learning (PFL) for 2-year MS disability progression…
Continue Reading
Life-Changing Results Through Advanced Telemedicine Technology
Cleveland Clinic’s innovative virtual second opinion program is revolutionizing neurological care through advanced telemedicine technology, providing life-changing results for patients nationwide who need expert specialist consultations.
Revolutionary Telemedicine Platform Connects…
Copenhagen-based digital health company specializing in chronic disease management, Dawn Health secured $13 million (€11.5 million) from existing investors Chr. Augustinus Fabrikker, the export and investment fund of Denmark (EIFO) and Trifork. WHAT IT DOES
Dawn…
Accurate assessment of progression and disease course in multiple sclerosis (MS) is vital for timely and appropriate clinical intervention. The gradual transition from relapsing-remitting MS (RRMS) to secondary progressive MS (SPMS) is often diagnosed…
Continue Reading
Background: Tools for measuring clinical disability status in people with multiple sclerosis (MS) are limited. Accelerometry objectively assesses physical activity and circadian rhythmicity profiles in the real-world environment and may potentially distinguish levels of…
Continue Reading
